Results 171 to 180 of about 7,672 (217)
Perioperative Management of a Patient With Wolff-Parkinson-White Syndrome Undergoing Thyroidectomy With Bilateral Modified Neck Dissection and the Role of Dexmedetomidine: A Case Report. [PDF]
CureusEjaz S, Ur Rehman H, Ashraf A.
europepmc +1 more source
Medication errors and adverse drug events in peri-operative pediatric anesthetic care over twenty years: a retrospective observational study. [PDF]
BMC AnesthesiolAbbasi S, Sharafat MA, Khan F.
europepmc +1 more source
Penehyclidine in prevention of postoperative nausea and vomiting: a systematic review and meta-analysis of randomized controlled trials. [PDF]
Front Med (Lausanne)Lu JC, Chen Y, Lai L, Shen QH.
europepmc +1 more source
Airway management of a Crouzon syndromic child with mid face distractor in situ for redo osteotomy. [PDF]
J Anaesthesiol Clin PharmacolManoharan KS, Rajan S, Paul J, Kumar L.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Anesthesia & Analgesia, 1987
Priming with atracurium was evaluated by dividing 39 patients into 2 groups. All received 0.2 mg IV glycopyrrolate and fentanyl, 50 micrograms IV. Group 1 received saline, group 2 received 0.06 mg/kg atracurium and a stop watch was started. After 3.5 min the patients were asked to lift their heads and maximum negative inspiratory pressure (MIP) was ...
M, Sosis, G E, Larijani, A T, Marr
openaire +2 more sources
Priming with atracurium was evaluated by dividing 39 patients into 2 groups. All received 0.2 mg IV glycopyrrolate and fentanyl, 50 micrograms IV. Group 1 received saline, group 2 received 0.06 mg/kg atracurium and a stop watch was started. After 3.5 min the patients were asked to lift their heads and maximum negative inspiratory pressure (MIP) was ...
M, Sosis, G E, Larijani, A T, Marr
openaire +2 more sources
Atracurium in the myasthenic patient
Anaesthesia, 1983Summary The use of the new competitive muscle relaxant, atracurium, is described in five myasthenic patients presenting for thymectomy. With an initial dose of 0.1 mg/kg, that is approximately one‐fifth of that normally used, and incremental doses of 0.02–0.04 mg/kg, satisfactory clinical conditions were achieved.
C F, Bell +4 more
openaire +2 more sources